182 related articles for article (PubMed ID: 29702023)
1. Skeletal Metastases and Benign Mimics on NaF PET/CT: A Pictorial Review.
Panagiotidis E; Lam K; Mistry A; Seshadri N; Vinjamuri S
AJR Am J Roentgenol; 2018 Jul; 211(1):W64-W74. PubMed ID: 29702023
[TBL] [Abstract][Full Text] [Related]
2.
Wondergem M; van der Zant FM; Knol RJJ; Burgers AMG; Bos SD; de Jong IJ; Pruim J
World J Urol; 2018 Jan; 36(1):27-34. PubMed ID: 29043431
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Challenge of Staging Metastatic Bone Disease in the Morbidly Obese Patients: A Primary Study Evaluating the Usefulness of 18F-Sodium Fluoride (NaF) PET-CT.
Usmani S; Marafi F; Ahmed N; Esmail A; Al Kandari F; Van den Wyngaert T
Clin Nucl Med; 2017 Nov; 42(11):829-836. PubMed ID: 28872551
[TBL] [Abstract][Full Text] [Related]
4. A proof-of-concept study analyzing the clinical utility of fluorine-18-sodium fluoride PET-CT in skeletal staging of oncology patients with end-stage renal disease on dialysis.
Usmani S; Marafi F; Esmail A; Ahmed N
Nucl Med Commun; 2017 Dec; 38(12):1067-1075. PubMed ID: 28953207
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of 18F-NaF PET/CT in bone metastasis detection and its effect on patient management in patients with breast carcinoma.
Broos WAM; van der Zant FM; Wondergem M; Knol RJJ
Nucl Med Commun; 2018 Apr; 39(4):325-333. PubMed ID: 29351123
[TBL] [Abstract][Full Text] [Related]
6. Technical feasibility, radiation dosimetry and clinical use of
Usmani S; Van den Wyngaert T; Ahmed N; Marafi F; Esmail A; Al Kandari F; Al Nuaimi M; Gnanasegaran G
Ann Nucl Med; 2018 Nov; 32(9):594-601. PubMed ID: 30019285
[TBL] [Abstract][Full Text] [Related]
7.
Sheikhbahaei S; Jones KM; Werner RA; Salas-Fragomeni RA; Marcus CV; Higuchi T; Rowe SP; Solnes LB; Javadi MS
Ann Nucl Med; 2019 May; 33(5):351-361. PubMed ID: 30877561
[TBL] [Abstract][Full Text] [Related]
8. Review of the role of MRI and 18 F-sodium fluoride PET/computed tomography in the characterisation of spinal bone metastases in a cohort of patients with breast cancer.
Panagiotidis E; Pant V; Vinjamuri S
Nucl Med Commun; 2023 Mar; 44(3):219-225. PubMed ID: 36592000
[TBL] [Abstract][Full Text] [Related]
9. Observer Agreement and Accuracy of
Zacho HD; Fonager RF; Nielsen JB; Haarmark C; Hendel HW; Johansen MB; Mortensen JC; Petersen LJ
J Nucl Med; 2020 Mar; 61(3):344-349. PubMed ID: 31481577
[TBL] [Abstract][Full Text] [Related]
10. The Role of 18F-Sodium Fluoride PET/CT Bone Scans in the Diagnosis of Metastatic Bone Disease from Breast and Prostate Cancer.
Kulshrestha RK; Vinjamuri S; England A; Nightingale J; Hogg P
J Nucl Med Technol; 2016 Dec; 44(4):217-222. PubMed ID: 27634981
[TBL] [Abstract][Full Text] [Related]
11. A Prospective Study Comparing
Löfgren J; Mortensen J; Rasmussen SH; Madsen C; Loft A; Hansen AE; Oturai P; Jensen KE; Mørk ML; Reichkendler M; Højgaard L; Fischer BM
J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
[TBL] [Abstract][Full Text] [Related]
12. Prospective comparative study of
Fonager RF; Zacho HD; Langkilde NC; Fledelius J; Ejlersen JA; Hendel HW; Haarmark C; Moe M; Mortensen JC; Jochumsen MR; Petersen LJ
Acta Oncol; 2018 Aug; 57(8):1063-1069. PubMed ID: 29447047
[TBL] [Abstract][Full Text] [Related]
13. Incremental Value of Cocktail 18F-FDG and 18F-NaF PET/CT Over 18F-FDG PET/CT Alone for Characterization of Skeletal Metastases in Breast Cancer.
Roop MJ; Singh B; Singh H; Watts A; Kohli PS; Mittal BR; Singh G
Clin Nucl Med; 2017 May; 42(5):335-340. PubMed ID: 28263210
[TBL] [Abstract][Full Text] [Related]
14. The value of quantitative analysis in
Lapa P; Marques M; Costa G; Lima JP
Rev Esp Med Nucl Imagen Mol; 2017; 36(2):78-84. PubMed ID: 27793635
[TBL] [Abstract][Full Text] [Related]
15. No Added Value of
Zacho HD; Jochumsen MR; Langkilde NC; Mortensen JC; Haarmark C; Hendel HW; Jensen JB; Petersen LJ
J Nucl Med; 2019 Dec; 60(12):1713-1716. PubMed ID: 31147402
[TBL] [Abstract][Full Text] [Related]
16. Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
Iagaru A; Young P; Mittra E; Dick DW; Herfkens R; Gambhir SS
Clin Nucl Med; 2013 Jul; 38(7):e290-6. PubMed ID: 23455520
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of false positive
Usmani S; Ahmed N; Muzaffar S; Marafi F; Esmail A; Gnanasegaran G; Van den Wyngaert T
Hell J Nucl Med; 2020; 23(1):67-75. PubMed ID: 32361718
[TBL] [Abstract][Full Text] [Related]
18. Newer PET application with an old tracer: role of 18F-NaF skeletal PET/CT in oncologic practice.
Bastawrous S; Bhargava P; Behnia F; Djang DS; Haseley DR
Radiographics; 2014; 34(5):1295-316. PubMed ID: 25208282
[TBL] [Abstract][Full Text] [Related]
19. Glioblastoma multiforme metastastic to the bone: diagnosis by (18)F-NaF PET/CT.
Derlin T; Clauditz TS; Bannas P
Clin Nucl Med; 2014 Feb; 39(2):188-9. PubMed ID: 24300358
[TBL] [Abstract][Full Text] [Related]
20. NaF PET/CT for response assessment of prostate cancer bone metastases treated with single fraction stereotactic ablative body radiotherapy.
Hardcastle N; Hofman MS; Lee CY; Callahan J; Selbie L; Foroudi F; Shaw M; Chander S; Lim A; Chesson B; Murphy DG; Kron T; Siva S
Radiat Oncol; 2019 Sep; 14(1):164. PubMed ID: 31488175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
